TGFB1 and neoplasm: First evidence for such immunosuppressive mechanisms in BCC came from studies of murine BCC models showing that transforming growth factor beta (TGFβ) secreted by oncogenic SMO-expressing keratinocytes is able to reduce the number of effector lymphocytes in the tumor tissue.